Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Glioma × Pharmacogenomic Testing × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Waldenstrom Macroglobulinemia 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Prolymphocytic 3 Breast Neoplasms 3 Sezary Syndrome 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Extranodal NK-T-Cell 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1

Interventions

Temozolomide 39 Radiotherapy 13 Magnetic Resonance Spectroscopy 9 Bevacizumab 8 Surgical Procedures, Operative 7 Irinotecan 7 Radiation 6 Carboplatin 6 ribociclib 5 Specimen Handling 5 Radiosurgery 5 Nivolumab 5 Imiquimod 5 Flucytosine 5 Filgrastim 5 Erlotinib Hydrochloride 5 Carmustine 5 Aminolevulinic Acid 5 vandetanib 4 sargramostim 4 Topotecan 4 O(6)-benzylguanine 4 Imatinib Mesylate 4 IL13-PE38 4 Etoposide 4 Cyclophosphamide 4 Craniotomy 4 vocimagene amiretrorepvec 3 lentiviral minigene vaccine of COVID-19 coronavirus 3 Thiotepa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01165333 2026-03-16

CILENT

Centre Oscar Lambret

Phase 1 Completed

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡